Stocks
Editas Medicine (EDIT) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.52 | 1.37 | 1.68 | 1.01 | 0.47 | 0.51 | |||
| Changes by years, y/y, % | -12% | -46% | +23% | -40% | -53% | -30.4% | |||
Editas Medicine. Debt/EBITDA
Editas Medicine. Debt/EBITDA, changes, %
Editas Medicine (EDIT) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | 0.80 | 0.73 | 0.83 | 0.47 | 0.51 | 0.51 | ||
| Changes by years, y/y, % | -45% | -37% | -20% | -54% | -37% | |||
| Changes by quarters, q/q, % | -21% | -9% | +13% | -43% | +9% | |||
